Suppr超能文献

微小RNA参与同型半胱氨酸诱导的心脏重塑。

MicroRNAs are involved in homocysteine-induced cardiac remodeling.

作者信息

Mishra Paras K, Tyagi Neetu, Kundu Soumi, Tyagi Suresh C

机构信息

Department of Physiology & Biophysics, University of Louisville, School of Medicine, A-1215, 500 South Preston Street, Louisville, KY, 40202, USA.

出版信息

Cell Biochem Biophys. 2009;55(3):153-62. doi: 10.1007/s12013-009-9063-6. Epub 2009 Aug 11.

Abstract

Elevated level of homocysteine (Hcy) called hyperhomocysteinemia (HHcy) is one of the major risk factors for chronic heart failure. Although the role of Hcy in cardiac remodeling is documented, the regulatory mechanism involved therein is still nebulous. MicroRNAs (miRNAs) and dicer have been implicated in regulation of cardiovascular diseases. Dicer is the only known enzyme involved in miRNA maturation. We investigated the involvement of dicer and miRNA in Hcy-induced cardiac remodeling. HL-1 cardiomyocytes were cultured in different doses of Hcy. Total RNA was isolated and RT-PCR and real-time PCR was performed for dicer, MMP-2,-9, TIMP-1,-3, and NOX-4. MiRNA microarray was used for analyzing the differential expression of miRNAs. Individual miRNA assay was also done. Western blotting was used to assess the MMP-9 expression in HHcy cardiomyocytes. The RT-PCR results suggest that dicer expression is enhanced in HHcy cardiomyocytes suggesting its involvement in cardiac remodeling caused due to high dose of Hcy. On the other hand, high dose of Hcy increased NOX-4 expression, a marker for oxidative stress. Additionally, HHcy cardiomyocytes showed elevated levels of MMP-2,-9 and TIMP-1,-3, and reduced expression of TIMP-4, suggesting cardiac remodeling due to oxidative stress. The miRNA microarray assay revealed differential expression of 11 miRNAs and among them miR-188 show dramatic downregulation. These findings suggest that dicer and miRNAs especially miR-188 are involved in Hcy-induced cardiac remodeling.

摘要

同型半胱氨酸(Hcy)水平升高即高同型半胱氨酸血症(HHcy),是慢性心力衰竭的主要危险因素之一。尽管Hcy在心脏重塑中的作用已有文献记载,但其涉及的调控机制仍不明确。微小RNA(miRNA)和Dicer酶与心血管疾病的调控有关。Dicer是唯一已知参与miRNA成熟的酶。我们研究了Dicer和miRNA在Hcy诱导的心脏重塑中的作用。将HL-1心肌细胞培养于不同剂量的Hcy中。提取总RNA,进行Dicer、基质金属蛋白酶-2、-9、组织金属蛋白酶抑制因子-1、-3和NADPH氧化酶4的逆转录聚合酶链反应(RT-PCR)和实时定量PCR。使用miRNA微阵列分析miRNA的差异表达。也进行了单个miRNA检测。采用蛋白质免疫印迹法评估HHcy心肌细胞中基质金属蛋白酶-9的表达。RT-PCR结果表明,HHcy心肌细胞中Dicer表达增强,提示其参与高剂量Hcy所致的心脏重塑。另一方面,高剂量Hcy增加了氧化应激标志物NADPH氧化酶4的表达。此外,HHcy心肌细胞中基质金属蛋白酶-2、-9和组织金属蛋白酶抑制因子-1、-3水平升高,组织金属蛋白酶抑制因子-4表达降低,提示存在氧化应激导致的心脏重塑。miRNA微阵列检测显示11种miRNA存在差异表达,其中miR-188显著下调。这些发现表明,Dicer和miRNA尤其是miR-188参与了Hcy诱导的心脏重塑。

相似文献

1
MicroRNAs are involved in homocysteine-induced cardiac remodeling.
Cell Biochem Biophys. 2009;55(3):153-62. doi: 10.1007/s12013-009-9063-6. Epub 2009 Aug 11.
2
4
Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes.
Mol Cell Biochem. 2015 Jun;404(1-2):241-50. doi: 10.1007/s11010-015-2383-5. Epub 2015 Mar 13.
5
Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.
Mol Cell Biochem. 2012 Dec;371(1-2):89-96. doi: 10.1007/s11010-012-1425-5. Epub 2012 Aug 12.
6
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Cardiovasc Diabetol. 2010 Sep 9;9:49. doi: 10.1186/1475-2840-9-49.
7
Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.
Curr Vasc Pharmacol. 2008 Apr;6(2):84-92. doi: 10.2174/157016108783955301.
8
Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
PLoS One. 2013 Dec 26;8(12):e83813. doi: 10.1371/journal.pone.0083813. eCollection 2013.
9
Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
Neurochem Int. 2008 Dec;53(6-8):214-9. doi: 10.1016/j.neuint.2008.07.008. Epub 2008 Aug 3.
10
Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism.
Physiol Genomics. 2014 Apr 1;46(7):245-55. doi: 10.1152/physiolgenomics.00168.2013. Epub 2014 Feb 4.

引用本文的文献

2
The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives.
Mamm Genome. 2024 Sep;35(3):309-323. doi: 10.1007/s00335-024-10043-6. Epub 2024 Jun 4.
4
Homocysteine as a Predictor of Paroxysmal Atrial Fibrillation-Related Events: A Scoping Review of the Literature.
Diagnostics (Basel). 2022 Sep 9;12(9):2192. doi: 10.3390/diagnostics12092192.
6
Roles of Exosomes and Exosomal MicroRNAs in Postoperative Sleep Disturbance.
Nat Sci Sleep. 2021 Jul 30;13:1363-1375. doi: 10.2147/NSS.S310351. eCollection 2021.
7
Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis.
Curr Hypertens Rep. 2021 May 7;23(5):28. doi: 10.1007/s11906-021-01142-9.
8
Identification of Circular RNA-MicroRNA-Messenger RNA Regulatory Network in Atrial Fibrillation by Integrated Analysis.
Biomed Res Int. 2020 Sep 29;2020:8037273. doi: 10.1155/2020/8037273. eCollection 2020.
10
Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases.
PLoS One. 2020 Jun 5;15(6):e0234185. doi: 10.1371/journal.pone.0234185. eCollection 2020.

本文引用的文献

1
MicroRNAs as a therapeutic target for cardiovascular diseases.
J Cell Mol Med. 2009 Apr;13(4):778-89. doi: 10.1111/j.1582-4934.2009.00744.x. Epub 2009 Mar 13.
2
MicroRNAs: target recognition and regulatory functions.
Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
5
Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Ann Thorac Surg. 2008 Oct;86(4):1243-9. doi: 10.1016/j.athoracsur.2008.06.043.
6
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.
Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H890-7. doi: 10.1152/ajpheart.00099.2008. Epub 2008 Jun 20.
7
MicroRNAs: novel regulators in cardiac development and disease.
Cardiovasc Res. 2008 Sep 1;79(4):562-70. doi: 10.1093/cvr/cvn137. Epub 2008 May 29.
8
MicroRNAs: role in cardiovascular biology and disease.
Clin Sci (Lond). 2008 Jun;114(12):699-706. doi: 10.1042/CS20070211.
9
Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus.
J Neurosci. 2008 Apr 23;28(17):4322-30. doi: 10.1523/JNEUROSCI.4815-07.2008.
10
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.
Cell. 2008 Mar 7;132(5):860-74. doi: 10.1016/j.cell.2008.02.020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验